Cawachi

Cawachi FCF Conversion

The FCF Conversion Rate (FCF/EBITDA) of Cawachi (2664.T) as of Nov 3, 2026 is 145.50 %. In the previous year, FCF Conversion Rate (FCF/EBITDA) was 69.66 % — a change of 108.88% (higher).

FCF Conversion

145.50 %

YoY

108.88%

Last updated:

FCF Conversion Rate (FCF/EBITDA) of Cawachi is 2026 145.50 % . FCF Conversion Rate (FCF/EBITDA) of Cawachi was 2025 69.66 % . It decreases by 108.88% higher compared to the previous year.

The Cawachi FCF Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Conversion
Date
FCF Conversion
Jan 1, 2019
194.10 JPY
Jan 1, 2020
220.85 JPY
Jan 1, 2021
170.00 JPY
Jan 1, 2022
49.05 JPY
Jan 1, 2023
98.40 JPY
Jan 1, 2024
21.71 JPY
Jan 1, 2025
69.66 JPY
Jan 1, 2026
145.50 JPY
The Cawachi FCF Conversion history
YEARFCF ConversionYoY
145.50 %+108.88%
69.66 %+220.91%
21.71 %-77.94%
98.40 %+100.61%
49.05 %-71.15%
170.00 %-23.03%
220.85 %+13.78%
194.10 %+198.59%
65.00 %-30.29%
93.25 %-65.84%
272.96 %+524.66%
43.70 %-67.92%
136.23 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cawachi Stock analysis

What does Cawachi do? Cawachi Ltd. generates revenue through the sale of pharmaceutical products such as cold medicines, digestive medicines, vitamin tablets, eye drops, and nursing care items. The company also sells cosmetics including basic skin care, makeup, and men's cosmetics, along with miscellaneous goods like detergents, toilet paper, pet items, and milk powders. Food products such as processed foods, dairy, confectioneries, and beverages are sold through its drugstores. The primary customers are retail consumers seeking health, beauty, and household essentials. The business segments include pharmaceuticals, cosmetics, miscellaneous goods, and food products, all distributed via Cawachi's drugstore network. Cawachi Ltd. operates a chain of drugstores that offer a wide range of health and personal care products. The company's product portfolio spans multiple categories, from medicine to daily necessities, targeting both individual shoppers and families. Its drugstores serve as one-stop shops for customers needing everyday items, combining health-focused products with general household goods. The business model relies on high-volume sales of these diverse product lines to drive profitability. The company's revenue streams are derived from direct sales to end consumers through its physical drugstore locations. Cawachi Ltd. does not mention any additional revenue sources such as online sales, subscriptions, or licensing. The focus remains on selling the listed product categories to retail customers in its drugstore network, with no indication of partnerships or third-party services. The business description emphasizes the range of products sold rather than specific customer demographics or pricing strategies. Cawachi is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Cawachi stock

FCF Conversion Rate (FCF/EBITDA) of Cawachi is 145.50 % in 2026.

FCF Conversion Rate (FCF/EBITDA) of Cawachi changed from 69.66 % to 145.50 %, representing a 108.88% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of FCF Conversion Rate (FCF/EBITDA) Cawachi since 2006 – with annual values, charts, and detailed analysis.

FCF conversion measures how effectively EBITDA converts to free cash flow. Higher conversion indicates efficient capital allocation and low maintenance costs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare FCF Conversion Rate (FCF/EBITDA)'s Cawachi with sector peers and the industry average to assess whether it is attractive.

To evaluate FCF Conversion Rate (FCF/EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for FCF Conversion Rate (FCF/EBITDA).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Cawachi

All Key Metrics — Cawachi